We describe a 18-year-old female with 22q13.3 deletion syndrome characterized by an alteration of SHANK3/PROSAP2 and severe mental retardation, intense psychomotor agitation and aggressive behaviour. When the patient was given risperidone, different therapeutic results were observed: at a 6 mg dose, risperidone had no therapeutic effect and the patient's behavioural problems increased; at a low dose (1mg), risperidone treatment resulted in rapid improvement of mood and behaviour. Recent findings suggest that risperidone exerts dose-dependent effects on Glu receptors in developing rats. An altered preset of the glutamate receptors, due to the presence of a haploinsufficiency of SHANK3/PROSAP2, could explain the different results of risperidone therapy observed in our patient with 22q13.3 deletion syndrome.

Pasini, A., D'Agati, E., Casarelli, L., Curatolo, P. (2010). Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome. BRAIN & DEVELOPMENT, 32(5), 425-427 [10.1016/j.braindev.2009.04.005].

Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome

PASINI, AUGUSTO;D'AGATI, ELISA;CURATOLO, PAOLO
2010-05-01

Abstract

We describe a 18-year-old female with 22q13.3 deletion syndrome characterized by an alteration of SHANK3/PROSAP2 and severe mental retardation, intense psychomotor agitation and aggressive behaviour. When the patient was given risperidone, different therapeutic results were observed: at a 6 mg dose, risperidone had no therapeutic effect and the patient's behavioural problems increased; at a low dose (1mg), risperidone treatment resulted in rapid improvement of mood and behaviour. Recent findings suggest that risperidone exerts dose-dependent effects on Glu receptors in developing rats. An altered preset of the glutamate receptors, due to the presence of a haploinsufficiency of SHANK3/PROSAP2, could explain the different results of risperidone therapy observed in our patient with 22q13.3 deletion syndrome.
mag-2010
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/39 - NEUROPSICHIATRIA INFANTILE
English
Animals; Chromosome Deletion; Dose-Response Relationship, Drug; Humans; Risperidone; Psychomotor Agitation; Antipsychotic Agents; Intellectual Disability; Pregnancy; Rats; Chromosomes, Human, Pair 22; Syndrome; Abnormalities, Multiple; Adolescent; Aggression; Female; Male
Pasini, A., D'Agati, E., Casarelli, L., Curatolo, P. (2010). Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome. BRAIN & DEVELOPMENT, 32(5), 425-427 [10.1016/j.braindev.2009.04.005].
Pasini, A; D'Agati, E; Casarelli, L; Curatolo, P
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/106029
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact